SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Roivant Sciences Ltd. (ROIV) has a negative trailing P/E of -24.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 150.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -4.11%, forward earnings yield 0.67%. PEG 0.36 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (68/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.36).
- Forward P/E 150.1 — analysts expect a return to profitability with estimated EPS of $0.19 for FY2029.
- PEG Ratio 0.36 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield -4.11% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 0.67% as earnings recover.
- Analyst consensus target $31.50 (+8.2% upside) — modest upside expected.
Overall SharesGrow Score: 64/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
68/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ROIV
Valuation Multiples
P/E (TTM)-24.3
Forward P/E150.1
PEG Ratio0.36
Forward PEG0.36
P/B Ratio4.61
P/S Ratio1,519.32
EV/EBITDA-18.7
Per Share Data
EPS (TTM)$-1.16
Forward EPS (Est.)$0.19
Book Value / Share$7.14
Revenue / Share$0.02
FCF / Share$-1.10
Yields & Fair Value
Earnings Yield-4.11%
Forward Earnings Yield0.67%
Dividend Yield0.00%
Analyst Target$31.50 (+8.2%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2020 |
5.9 |
0.00 |
3.50 |
105.21 |
- |
| 2021 |
-8.3 |
0.05 |
3.53 |
281.46 |
- |
| 2022 |
-3.9 |
-0.58 |
2.00 |
59.84 |
- |
| 2023 |
-5.2 |
-0.41 |
4.54 |
85.84 |
- |
| 2024 |
1.9 |
0.00 |
1.37 |
249.73 |
0.07% |
| 2025 |
-42.6 |
0.41 |
1.56 |
251.93 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$5.21 |
$67.69M |
$1.2B |
1773.6% |
| 2020 |
$-1.18 |
$23.8M |
$-809.23M |
-3400.9% |
| 2021 |
$-1.26 |
$55.29M |
$-845.26M |
-1528.9% |
| 2022 |
$-1.42 |
$61.28M |
$-1.01B |
-1646.6% |
| 2023 |
$5.23 |
$124.8M |
$4.35B |
3484.9% |
| 2024 |
$-0.24 |
$29.05M |
$-171.98M |
-592% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-1.12 |
$-5.38 – $0.16 |
$9.39M |
$5.73M – $18.5M |
4 |
| 2027 |
$-1.18 |
$-1.28 – $-1.09 |
$44.74M |
$4.52M – $146.53M |
4 |
| 2028 |
$-1.00 |
$-1.48 – $-0.20 |
$513.21M |
$494.01M – $532.42M |
7 |
| 2029 |
$0.28 |
$-1.81 – $1.89 |
$1.74B |
$205.05M – $6.83B |
4 |
| 2030 |
$1.09 |
$-0.16 – $5.25 |
$2.99B |
$353.58M – $11.77B |
2 |
